Home
Neuland Laboratories Ltd EPS

Neuland Laboratories Ltd
NSE: NEULANDLAB
EPS
Key Highlights
- The Earning per Share of Neuland Laboratories Ltd is ₹ 187.04 as of 21 Feb 25 .
- The earning per share of Neuland Laboratories Ltd changed from ₹ 48.23 to ₹ 79.18 over 7 quarters. This represents a CAGR of 32.75% .
Historical Earning per Share of Neuland Laboratories Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Neuland Laboratories Ltd
Company Fundamentals for Neuland Laboratories Ltd
Market Cap
14,109 Cr
EPS
187.0
P/E Ratio (TTM)
58.8
P/B Ratio (TTM)
10.1
Day’s High
11558.65
Day’s Low
10937.6
DTE
0.1
ROE
20.0
52 Week High
18089.55
52 Week Low
5532.5
ROCE
25.7
Market Price of Neuland Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 10997.15 |
20 Feb 2025 | 11419.5 |
19 Feb 2025 | 11170.95 |
18 Feb 2025 | 11026.85 |
17 Feb 2025 | 11554.2 |
14 Feb 2025 | 11768.4 |
13 Feb 2025 | 12702.5 |
12 Feb 2025 | 13658.5 |
11 Feb 2025 | 13659.05 |
10 Feb 2025 | 14663.8 |
SWOT Analysis Of Neuland Laboratories Ltd
BlinkX Score for Neuland Laboratories Ltd
Asset Value vs Market Value of Neuland Laboratories Ltd
Market Value
₹ 14,109
Asset Value
Value addition
14.1 X
₹ 934
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Neuland Laboratories Ltd | 14109 | 187.04 |
Sun Pharmaceuticals Industries Ltd | 394223 | 49.16 |
Divis Laboratories Ltd | 152610 | 77.86 |
Cipla Ltd | 119067 | 61.78 |
Torrent Pharmaceuticals Ltd | 102739 | 55.02 |
Dr Reddys Laboratories Ltd | 96124 | 64.37 |
Company | |
---|---|
Neuland Laboratories Ltd | 14109 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
Historical Market Cap of Neuland Laboratories Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Neuland Laboratories Ltd
Historical Revenue of Neuland Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Neuland Laboratories Ltd
Historical EBITDA of Neuland Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Neuland Laboratories Ltd
Historical Net Profit of Neuland Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Neuland Laboratories Ltd
Dividend Payout Over Time
Neuland Laboratories Ltd News Hub
Neuland Laboratories consolidated net profit rises 58.16% in the June 2024 quarter
Net profit of Neuland Laboratories rose 58.16% to Rs 97.87 crore in the quarter ended June 2024 as a
Read more
01 Aug 24
Neuland Laboratories to declare Quarterly Result
Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 6 November 2024
Read more
18 Oct 24
Neuland Laboratories consolidated net profit declines 63.20% in the September 2024 quarter
Net profit of Neuland Laboratories declined 63.20% to Rs 32.84 crore in the quarter ended September
Read more
06 Nov 24
Neuland Laboratories Ltd leads losers in 'A' group
Hindustan Zinc Ltd, Five-Star Business Finance Ltd, Great Eastern Shipping Company Ltd and Triveni E
Read more
06 Nov 24
Document
Concalls